Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for

See also
Status	Clinical Trial	Phase
Completed	`NCT00001972` - PET Scan of Brain Metabolism in Relation to Age and Disease	N/A
Completed	`NCT02798406` - Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects	Phase 2
Terminated	`NCT02855086` - Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery	Phase 1/Phase 2
Terminated	`NCT00638963` - Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)	Phase 2
Withdrawn	`NCT03234309` - Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors	Phase 2
Completed	`NCT00178295` - Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury	N/A
Recruiting	`NCT04810871` - Surgical Resection of Latent Brain Tumors Prior to Recurrence	N/A
Recruiting	`NCT02800486` - Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA	Phase 2
Completed	`NCT01621295` - Assessing the Patient Experience in Cancer Care	N/A
Completed	`NCT02964416` - Single Dose Tramadol Effect on Extubation Response and Quality of Emergence Post-supratentorial Intracranial Surgery	Phase 4
Completed	`NCT00001574` - A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors
Recruiting	`NCT02861898` - Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma	Phase 1/Phase 2
Completed	`NCT00040573` - Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.	Phase 1/Phase 2
Active, not recruiting	`NCT04553757` - Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma
Recruiting	`NCT02754544` - Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors	N/A
Recruiting	`NCT03216148` - 18F-FET PET in Childhood Brain Tumours	Phase 2
Completed	`NCT00001171` - Evaluation of Factors in Human Brain Tumors	N/A
Withdrawn	`NCT01413438` - Bevacizumab With or Without Surgery for Adult Glioblastomas	Phase 2
Not yet recruiting	`NCT05516485` - Measuring Brain Tumor Consistency Using Magnetic Resonance Elastography	N/A
Recruiting	`NCT02639325` - Tumor Related Epilepsy

NCT number	NCT02755142
Study type	Interventional
Source	medac GmbH
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	February 2000
Completion date	June 2001

Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms